1. Home
  2. ELVN vs EH Comparison

ELVN vs EH Comparison

Compare ELVN & EH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • EH
  • Stock Information
  • Founded
  • ELVN 2016
  • EH 2014
  • Country
  • ELVN United States
  • EH China
  • Employees
  • ELVN N/A
  • EH N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • EH Military/Government/Technical
  • Sector
  • ELVN Health Care
  • EH Industrials
  • Exchange
  • ELVN Nasdaq
  • EH Nasdaq
  • Market Cap
  • ELVN 1.2B
  • EH 1.4B
  • IPO Year
  • ELVN 2020
  • EH 2019
  • Fundamental
  • Price
  • ELVN $20.52
  • EH $17.65
  • Analyst Decision
  • ELVN Strong Buy
  • EH Strong Buy
  • Analyst Count
  • ELVN 5
  • EH 3
  • Target Price
  • ELVN $41.20
  • EH $24.80
  • AVG Volume (30 Days)
  • ELVN 399.0K
  • EH 1.2M
  • Earning Date
  • ELVN 11-12-2025
  • EH 11-17-2025
  • Dividend Yield
  • ELVN N/A
  • EH N/A
  • EPS Growth
  • ELVN N/A
  • EH N/A
  • EPS
  • ELVN N/A
  • EH N/A
  • Revenue
  • ELVN N/A
  • EH $65,001,814.00
  • Revenue This Year
  • ELVN N/A
  • EH $16.56
  • Revenue Next Year
  • ELVN $20.05
  • EH $84.86
  • P/E Ratio
  • ELVN N/A
  • EH N/A
  • Revenue Growth
  • ELVN N/A
  • EH 87.04
  • 52 Week Low
  • ELVN $13.30
  • EH $12.02
  • 52 Week High
  • ELVN $29.79
  • EH $29.76
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 49.61
  • EH 47.22
  • Support Level
  • ELVN $21.08
  • EH $17.05
  • Resistance Level
  • ELVN $22.36
  • EH $18.20
  • Average True Range (ATR)
  • ELVN 1.00
  • EH 0.86
  • MACD
  • ELVN 0.04
  • EH -0.12
  • Stochastic Oscillator
  • ELVN 43.98
  • EH 26.30

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About EH EHang Holdings Limited ADS

EHang Holdings Ltd is an urban air mobility (UAM) technology platform company. It focuses on making safe, autonomous, eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with unmanned aerial vehicle (UAV) systems and solutions: air mobility (including passenger transportation and logistics), smart city management, and aerial media solutions. EHang's EH216-S has received a production certificate and standard airworthiness certificate for passenger-carrying pilotless eVTOL aircraft issued by the Civil Aviation Administration of China. The group continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.

Share on Social Networks: